If O'Leary wishes to make a difference, it would be more effective for her to align her message with that of the broader patient community.
This would require her to be open to consulting with, and listening to patients, carers and advocates and a willingness to assimilate patient experience and knowledge - as opposed to presenting her beliefs and ideas in presentations and briefing papers that appear to have been prepared in isolation.
She's said on Twitter that she's looking forward to reviewing insights from the group [Sheffield ME & Fibromyalgia] in the [presentation] recording and that there were "some terrific questions that helped to clarify a productive path forward".
A "productive path forward" for whom?
A number of us spent considerable time and energy setting out in the BMJ Greenhalg Long Covid management
article/Rapid Responses thread the flaws in her pitch for handing "CFS" to the psychs and that the term "CFS" could then be repurposed for Long Covid patients and others with (verbatim quote)
"a psychiatric condition that sometimes develops in reaction to acute viral infection.[2] [3] [4] It is essentially deconditioning that arises from inactivity when patients embrace faulty illness beliefs."
Has she returned to that thread and addressed these concerns? No. They are left hanging.
Diane O'Leary should be experienced in advocating for patient groups. She lives in the U.S. and has written in U.S. media about how she was initially misdiagnosed with CFS then eventually correctly diagnosed with Sneddon syndrome (a rare, genetic, progressive condition that affects blood vessels). For some years, she collaborated with rare disease organisations and she also ran a patient org for people with Sneddon syndrome.
But her advocacy style seems to be:
a) This is how I see it.
b) This is what must be done to achieve my objectives.
c) I don't understand why you patients wouldn't want this, too.
That is not advocacy.
[Edited to insert verbatim quote.]